A randomized double-blind multicenter study of Yuyin Lotion in the treatment of scalp psoriasis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052738

Enrollment

Unknown

Registered

2021-11-04

Start date

2022-03-01

Completion date

Unknown

Last updated

2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scalp psoriasis

Interventions

Control group:Placebo

Experimental group:Yuyin Lotion

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years. 2. Meet the diagnostic criteria for psoriasis vulgaris. 3. There are skin lesions on the scalp. 4. Winter type, stable patients. 5. Patients with mild to moderate scalp disease (PSSI score 12-18 points or IGA score 2-3 points). 6. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the related pharmaceutical ingredients of Yuyin Lotion. 2. Patients who are pregnant, planning to become pregnant or breastfeeding. 3. Topical glucocorticoids, calcipotriol and retinoic acid have been used on the scalp within 2 weeks. 4. Systemic use of glucocorticoids, immunosuppressive agents, retinoic acid drugs, and oral traditional Chinese medicine within 4 weeks. 5. Biologics have been used within 12 weeks.

Design outcomes

Secondary

Measure	Time frame
Investigator's overall rating score;Patient's overall evaluation score;Scalp Quality of Life Score;Skin Lens Psoriasis Severity Index Score;Degree of scalp itching;	—

Primary

Measure	Time frame
Psoriasis Scalp Severity Index Score;	—

Countries

China

Contacts

Public ContactCui Bingnan

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

1998@163.com+86 15010459211

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026